drugset / Trial / NCT04788953

Clinical Trial of Solriamfetol for Excessive Sleepiness Related to Shift Work Disorder

NCT04788953

RandomizedParallel-groupQuadruple-blindTreatment

Summary

In this research study the investigators want to learn more about whether the medication Solriamfetol improves daytime sleepiness in workers who start work at very early times (between 3 and 6am).

Timeline

Start
2021-07-21
Primary completion
2024-04-06
Completion
2024-04-19

Drugs

EvaluationDrugModalityDoseRoute
Subject Solriamfetol Small molecule 150 mg Oral